drugset / Trial / NCT00548119

NeoCart Phase 2 Clinical Trial

NCT00548119 ↗

Phase 2 Completed 30 enrolled Histogenics Corporation
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to gather additional information regarding the performance of NeoCart to fill articular cartilage defects in the knee.

Timeline

Start
2006-12
Primary completion
2009-11
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject NeoCart Cell therapy — —